Preview
Enthusiasm for thrombolytic agents has led to an explosion of research and clinical trials. These have yielded diverse conclusions, usually because of differences in patient enrollment, end points analyzed, and treatment protocols. Some of the resulting misconceptions about this rapidly changing field are clarified in this concise review.